Total submissions: 24
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV003315712 | SCV000153970 | benign | Familial adenomatous polyposis 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000211906 | SCV000167004 | benign | not specified | 2014-02-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000129160 | SCV000183890 | benign | Hereditary cancer-predisposing syndrome | 2014-11-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genomic Diagnostic Laboratory, |
RCV000202973 | SCV000257784 | benign | Familial multiple polyposis syndrome | 2015-03-25 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000307559 | SCV000452000 | benign | APC-Associated Polyposis Disorders | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
ARUP Laboratories, |
RCV000211906 | SCV000602504 | benign | not specified | 2019-02-12 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000129160 | SCV000681582 | benign | Hereditary cancer-predisposing syndrome | 2016-03-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000211906 | SCV000805388 | benign | not specified | 2016-11-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001529443 | SCV001746824 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | APC: BP4, BP7, BS1 |
Genetic Services Laboratory, |
RCV000211906 | SCV002069698 | benign | not specified | 2020-04-22 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000129160 | SCV002532488 | benign | Hereditary cancer-predisposing syndrome | 2020-08-26 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000211906 | SCV002550611 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003315712 | SCV004015691 | benign | Familial adenomatous polyposis 1 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Institute for Biomarker Research, |
RCV000129160 | SCV004228055 | benign | Hereditary cancer-predisposing syndrome | 2023-12-12 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001353666 | SCV000591131 | benign | Carcinoma of colon | no assertion criteria provided | clinical testing | The APC, p.Ile1055Ile variant was not identified in the literature nor was it identified in the GeneInsight COGR through the Canadian Open Genetics Repository, CLINVITAE, COSMIC or MutDB databases. The variant was identified in dbSNP (ID: rs61734287 “With Benign allele”, with a minor allele frequency of 0.001(5 of 5000 in 1000 Genomes Project). In NHLBI Exome Sequencing Project (Exome Variant Server) the variant was identified in 34 of 8600 European Americans and 4 of 4405 African Americans. In the Exome Aggregation Consortium (ExAC) database (released Oct 20th, 2014), the variant was identified in 428 of 120724 chromosomes (frequency: 0.003545) (or 394 of 66424 alleles in the European (Non-Finnish) - 2 of them homozygous, 17 of 6610 alleles in the European (Finnish), 7 of 10258 of Africans, 6 of 11508 Latinos, 4 of 16456 South Asians), increasing the likelihood this could be a low frequency benign variant. The variant was also identified in the Clinvar database and classified as benign by Invitae, by Gene DX and by Ambry genetics; classified as neutral in UMD database and co-occurred with a pathogenic variant - APC: c.1248C>G, p.Tyr416X. It was identified 2X in InSiGHT Colon Cancer Database and 1X in Zhejiang Colon Cancer Database.The p.Ile1055Ile variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information, this variant meets our laboratory's criteria to be classified as benign. | |
Mayo Clinic Laboratories, |
RCV000211906 | SCV000691730 | likely benign | not specified | no assertion criteria provided | clinical testing | ||
True Health Diagnostics | RCV000129160 | SCV000693475 | likely benign | Hereditary cancer-predisposing syndrome | 2017-09-11 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV001529443 | SCV001742912 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001529443 | SCV001800609 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000211906 | SCV001807284 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001529443 | SCV001922002 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001529443 | SCV001958003 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000211906 | SCV001972576 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000211906 | SCV002033980 | benign | not specified | no assertion criteria provided | clinical testing |